KALVISTA PHARMACEUTICALS, INC.

CAMBRIDGE, MA How do I update this listing?

Kalvista Pharmaceuticals is based out of Cambridge. Carbylan Therapeutics Inc operates as a clinical-stage specialty pharmaceutical company. The Company focuses on the development and commercialization of medicine for pain treatment associated with osteoarthritis, joint pain relief, and OA pain. Carbylan Therapeutics serves clients globally.Whalewisdom has at least 79 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-03-05. The notice included securities offered of Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

kalvista pharmaceuticals, inc.
55 CAMBRIDGE PARKWAY
CAMBRIDGE MA    02142

Business Phone: (857) 999-0075
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-03-05 D OTHER HEALTH CARE Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,000,000 4,000,000 0
2014-10-14 D OTHER HEALTH CARE Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,000,000 5,000,000 0
2013-01-03 D OTHER HEALTH CARE Equity 13,228,600 5,999,999 7,228,601
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALBERT CHA subscription required
    DIRECTOR
CHRIS EHRLICH subscription required
    DIRECTOR
DAVID CLAPPER subscription required
    DIRECTOR
DAVID GRAVETT subscription required
    EXECUTIVE OFFICER
DAVID M. RENZI subscription required
    EXECUTIVE OFFICER DIRECTOR
EDWARD W. UNKART subscription required
    DIRECTOR
GEORGE DANILOFF subscription required
    EXECUTIVE OFFICER DIRECTOR
GUY NOHRA subscription required
    DIRECTOR
HAYLEY LEWIS subscription required
    EXECUTIVE OFFICER
KEITH A. KATKIN subscription required
    DIRECTOR
MARCEE MARONEY subscription required
    EXECUTIVE OFFICER
MARK WEEKS subscription required
    EXECUTIVE OFFICER
REZA ZADNO subscription required
    DIRECTOR
ROXANNE DUBOIS subscription required
    EXECUTIVE OFFICER
STEVEN BASTA subscription required
    DIRECTOR
T. MICHAEL WHITE subscription required
    EXECUTIVE OFFICER
TIMOTHY L. TRAPP subscription required
    EXECUTIVE OFFICER

Elevate your investments